CSIMarket
 


Sight Sciences Inc   (NASDAQ: SGHT)
Other Ticker:  
 

Sight Sciences Inc 's Quick Ratio

SGHT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

 


Current Liabilities decreased faster than Sight Sciences Inc 's Cash & cash equivalent, this led to improvement in Sight Sciences Inc 's Quick Ratio to 8.97, Quick Ratio remained below Sight Sciences Inc average.

Within Medical Equipment & Supplies industry 11 other companies have achieved higher Quick Ratio than Sight Sciences Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 231, from total ranking in the fourth quarter 2024 at 241.

Explain Quick Ratio?
How much Cash & cash equivalents SGHT´s has?
What are SGHT´s Current Liabilities?


SGHT Quick Ratio (Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
Y / Y Current Liabilities Change 3.67 % 26.25 % -3.71 % -5.44 % -22.79 %
Y / Y Cash & cash equivalent Change -14.55 % -12.87 % -17.95 % -23.52 % -23.93 %
Quick Ratio MRQ 8.97 7.78 8.59 8.89 10.89
SGHT's Total Ranking # 231 # 241 # 332 # 329 # 0
Seq. Current Liabilities Change -21.63 % 12.1 % 3.85 % 13.64 % -4.56 %
Seq. Cash & cash equivalent Change -9.63 % 1.51 % 0.33 % -7.15 % -7.85 %



Quick Ratio first quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 118
Overall Market # 231


Quick Ratio Statistics
High Average Low
26.32 12.15 2.95
(Sep 30 2021)   (Jun 30 2021)




Financial Statements
Sight Sciences Inc 's Current Liabilities $ 12 Millions Visit SGHT's Balance sheet
Sight Sciences Inc 's Cash & cash equivalent $ 109 Millions Visit SGHT's Balance sheet
Source of SGHT's Sales Visit SGHT's Sales by Geography


Cumulative Sight Sciences Inc 's Quick Ratio

SGHT's Quick Ratio for the trailling 12 Months

SGHT Quick Ratio

(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 4.49 % -2.75 % -16.81 % -19.93 % -18.93 %
Y / Y Cash & cash equivalent TTM Growth -17.46 % -19.87 % -22.91 % -25.27 % -26.91 %
Quick Ratio TTM 8.52 8.93 9.84 10.24 10.79
Total Ranking TTM # 2584 # 2644 # 2868 # 2851 # 0
Seq. Current Liabilities TTM Growth 0.79 % 6.3 % -1.03 % -1.46 % -6.19 %
Seq. Cash & cash equivalent TTM Growth -3.82 % -3.54 % -4.91 % -6.44 % -6.63 %


On the trailing twelve months basis Due to decline in Current Liabilities in the Q1 2025 to $12.12 millions, cumulative Quick Ratio decreased to 8.52 below the Sight Sciences Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 145 other companies have achieved higher Quick Ratio than Sight Sciences Inc . While Quick Ratio overall ranking has improved so far to 2584, from total ranking during the twelve months ending fourth quarter 2024 at 2644.

Explain Quick Ratio?
How much Cash & cash equivalents SGHT´s has?
What are SGHT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 146
Healthcare Sector # 742
Within the Market # 2584


trailing twelve months Quick Ratio Statistics
High Average Low
19.81 12.19 8.52
(Jun 30 2022)   (Mar 31 2025)




Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry Quick RatioMar 31 2025 MRQ Cash & cash equivalentMar 31 2025 MRQ Current Liabilities
Envveno Medical Corporation  23.44 $ 38.941  Millions$ 1.661  Millions
Utah Medical Products Inc  19.27 $ 83.325  Millions$ 4.324  Millions
Soleno Therapeutics Inc  18.43 $ 289.950  Millions$ 15.731  Millions
Ceribell Inc   17.38 $ 182.700  Millions$ 10.512  Millions
Microbot Medical Inc   16.88 $ 30.438  Millions$ 1.803  Millions
Perspective Therapeutics Inc   16.70 $ 211.702  Millions$ 12.679  Millions
Pulse Biosciences Inc   15.37 $ 119.279  Millions$ 7.760  Millions
Beta Bionics Inc   14.04 $ 231.473  Millions$ 16.492  Millions
Innovative Eyewear Inc   13.31 $ 5.258  Millions$ 0.395  Millions
Lemaitre Vascular Inc   12.23 $ 302.549  Millions$ 24.745  Millions
Cvrx inc   12.07 $ 102.668  Millions$ 8.508  Millions
Delcath Systems Inc   11.38 $ 58.896  Millions$ 5.177  Millions
Bone Biologics Corporation  11.08 $ 2.747  Millions$ 0.248  Millions
Talkspace Inc   10.29 $ 108.351  Millions$ 10.526  Millions
Rxsight Inc   10.08 $ 229.341  Millions$ 22.741  Millions
Orasure Technologies Inc  9.74 $ 247.569  Millions$ 25.422  Millions
Sight Sciences Inc   8.97 $ 108.768  Millions$ 12.122  Millions
Profound Medical Corp   8.77 $ 46.433  Millions$ 5.295  Millions
Monogram technologies inc   6.71 $ 13.270  Millions$ 1.978  Millions
Procept Biorobotics Corporation  6.07 $ 316.207  Millions$ 52.064  Millions
Iradimed Corporation  5.94 $ 50.331  Millions$ 8.473  Millions
Inspire Medical Systems inc   5.82 $ 369.189  Millions$ 63.470  Millions
Alpha Pro Tech Ltd   5.79 $ 13.352  Millions$ 2.306  Millions
Vicarious Surgical Inc  5.67 $ 37.362  Millions$ 6.592  Millions
Irhythm Technologies Inc   5.66 $ 520.589  Millions$ 91.922  Millions
Transmedics Group Inc   5.58 $ 310.143  Millions$ 55.603  Millions
Outset Medical Inc   5.52 $ 189.002  Millions$ 34.223  Millions
Autonomix Medical Inc   5.35 $ 9.136  Millions$ 1.707  Millions
Tenon Medical Inc  4.70 $ 10.311  Millions$ 2.195  Millions
Glucotrack Inc   4.67 $ 9.100  Millions$ 1.950  Millions

Date modified: 2025-05-11T14:53:35+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com